Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part I
about
Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanismRabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicineThematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemiaThe pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part IV: the 1984 coronary primary prevention trial ends it--almostThematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part II: the early evidence linking hypercholesterolemia to coronary disease in humansThematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversyThermal intravascular photoacoustic imaging.Seeking a unique lipid signature predicting cardiovascular disease risk.Cholesterol in the retina: the best is yet to come.Context-dependent associations between variation in risk of ischemic heart disease and variation in the 5' promoter region of the apolipoprotein E gene in Danish women.Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic strokeContribution of regulatory and structural variations in APOE to predicting dyslipidemia.A systems biology approach to understanding atherosclerosis.Reactive Secondary Sequence Oxidative Pathology Polymer Model and Antioxidant Tests.ApoB siRNA-induced liver steatosis is resistant to clearance by the loss of fatty acid transport protein 5 (Fatp5)If It's Not One Thing, It's Another: An Inverse Relationship of Malignancy and Atherosclerotic Disease.Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9Cholesteryl ester transfer protein (CETP) I405V polymorphism and cardiovascular disease in eastern European Caucasians - a cross-sectional studyDyslipidemia: evidence of efficacy of the pharmacological and non-pharmacological treatment in the elderly.Variation in 5' promoter region of the APOE gene contributes to predicting ischemic heart disease (IHD) in the population at large: the Copenhagen City Heart StudyPCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE.The "Mevalonate hypothesis": a cholesterol-independent alternative for the etiology of atherosclerosis.Fundamental research is the basis for understanding and treatment of many human diseases.Hyperlipidemia as a risk factor for cardiovascular disease.Guar gum and similar soluble fibers in the regulation of cholesterol metabolism: current understandings and future research priorities.Advances in the management of hyperlipidemia-induced atherosclerosis.Strengthening causal inference in cardiovascular epidemiology through Mendelian randomization.Pathways from science findings to health benefits.Influence of genotype on the modulation of gene and protein expression by n-3 LC-PUFA in rats.Inhibition of pro-protein convertase subtilisin kexin 9 [corrected] (PCSK-9) as a treatment for hyperlipidaemia.Macrophage differentiation and function in atherosclerosis: opportunities for therapeutic intervention?A case study of single-pill combination therapy: the ezetimibe/simvastatin combination for treatment of hyperlipidemia.Shaggy and calcified aorta: surgical implications.Predictors of cardiovascular risk in women.The action of peroxyl radicals, powerful deleterious reagents, explains why neither cholesterol nor saturated fatty acids cause atherogenesis and age-related diseases.Fibrates and niacin: is there a place for them in clinical practice?The early years of lipoprotein research: from discovery to clinical application.Oxidation hypothesis of atherogenesis: HDL inflammatory index and apolipoprotein A-I mimetic peptides.Lysosomes, cholesterol and atherosclerosis.Retracted: Advances in the physiological and pathological implications of cholesterol.
P2860
Q24603957-DA06B287-61E6-4FFC-A9EE-C638E1427E0DQ26853133-E6116F2C-DD8C-4937-93B0-CC2C1B50310AQ28259861-1D5C871C-3E1A-47D2-BE88-E809C9504D08Q28277233-E86541B0-5157-4492-8FDA-4D4B8751E541Q28293788-2CCFBB25-66CE-4FC5-82AE-7C4EEA88F8FFQ28305315-89463B27-1A5A-473B-AA0B-187BB5210FCAQ30472966-4C6E8242-26E5-41B1-BFFF-6299F4A28B01Q33600581-C5FB96BA-B2A8-4F02-B68A-5D2D717D3283Q33758267-225675DC-0524-42CD-9A08-787E7E608669Q33775392-264CD943-04AE-44F3-BEA6-61E8AF3A43A8Q34095488-3B2E90AC-604F-4472-848A-A7FA5F333D93Q34338601-8B2D4050-04A8-4C55-BD0D-61DE9C874C7AQ34355117-7BC0F721-A813-41DE-874A-ACA9C08DC5E6Q35504522-9686252D-1967-45F4-A2F6-38C8AED2DFD1Q35541914-E9E38DDC-26FF-43CE-A7B4-85B7944AD59FQ35637017-5280D58A-AD26-4685-9A42-7BC3ECDABC37Q35771131-0BE7BBA5-03EF-435C-B763-7EA161998117Q36083105-C4340A89-87B1-48CF-BB7F-9CC20EF1965EQ36163667-8547DE2A-A6C0-4A7C-B177-4A0E66706383Q36168772-435DE74F-47E5-49AC-98A1-434D116ECADBQ36196833-3027D3A9-BD98-4E00-8178-FCAF6BD1546AQ36394541-B7EE2284-5F82-4777-B34B-865772DA9A20Q36522101-FB4F7C8F-8B6D-456D-9C2A-06CA6877E8BDQ36609968-CB2A9F93-7422-47E9-ABB6-F59BB4A8BB0AQ37019897-CD335840-4468-4767-AB38-067AFAADE22CQ37104870-F5262C6C-F69D-472F-8035-392A509D44E9Q37209749-A334879E-D9E8-4494-AD1C-EB009BDF5274Q37242952-9937ADC4-CB35-41A0-AB04-49F506D9C9AEQ37299994-15175B47-B392-49F5-A574-7868ECF27E66Q38001736-BC4EEA57-BC39-4B88-8E45-7BF501F73460Q38008842-3F49236C-AF93-4208-839A-1F6DE5FE6F47Q38036194-BE85F970-C1A3-448E-8A4B-8BDD31E24330Q38081092-B6F55541-359D-46B0-AE80-E1611444875EQ38134402-DF87DF9E-B108-4371-AE52-182EB29810D7Q38260486-D0B46280-3AB7-46F2-A4DB-1C41B7966C3AQ38260501-367B3E9E-CDB8-4660-8BA0-345F03C932D5Q38913108-9C83B484-AE1A-4F10-B062-9DCE6FAB833DQ40218716-6AC8425E-7FBA-46DE-BD95-7710A9956E79Q42122586-B5D060E2-70DB-4B70-8DFB-0076C8EF10D7Q46069993-BBA86347-1D34-4DF8-B1D8-6C61F664B464
P2860
Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part I
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Thematic review series: the pa ...... holesterol controversy: part I
@ast
Thematic review series: the pa ...... holesterol controversy: part I
@en
Thematic review series: the pa ...... holesterol controversy: part I
@nl
type
label
Thematic review series: the pa ...... holesterol controversy: part I
@ast
Thematic review series: the pa ...... holesterol controversy: part I
@en
Thematic review series: the pa ...... holesterol controversy: part I
@nl
prefLabel
Thematic review series: the pa ...... holesterol controversy: part I
@ast
Thematic review series: the pa ...... holesterol controversy: part I
@en
Thematic review series: the pa ...... holesterol controversy: part I
@nl
P2860
P3181
P1476
Thematic review series: the pa ...... holesterol controversy: part I
@en
P2093
Daniel Steinberg
P2860
P304
P3181
P356
10.1194/JLR.R400003-JLR200
P407
P577
2004-09-01T00:00:00Z